A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Allen Lee Cohn, MD
Rocky Mountain Cancer Centers
Principal Investigator - David A. Smith, MD
Northwest Cancer Specialists - Vancouver Cancer Center
Principal Investigator - Donald A. Richards, MD
Texas Oncology - Tyler
Principal Investigator - Edward Sausville, MD
University of Maryland Greenebaum Cancer Center
Principal Investigator - Fadi Braiteh, MD
Comprehensive Cancer Centers of Nevada
Principal Investigator - Glen J Weiss, MD
TGen Clinical Research Services at Scottsdale Healthcare
Principal Investigator - Hillary H. Wu, MD
Central Indiana Cancer Centers
Principal Investigator - John R. Caton, MD
Willamette Valley Cancer Institute and Research Center
Principal Investigator - Lawrence Garbo, MD
New York Oncology Hematology
Principal Investigator - Paul R. Conkling, MD
Virginia Oncology Associates
Principal Investigator - Stephen Anthony, MD
Evergreen Hematology & Oncology
Principal Investigator - William J Edenfield, MD
Institute for Translational Oncology Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tgen Clinical Research Services at Scottsdale Healthcare
Scottsdale, Arizona, United States
- Rocky Mountain Cancer Centers
Denver, Colorado, United States
- Central Indiana Cancer Centers
Indianapolis, Indiana, United States
- University of Maryland, Greenebaum Cancer Center
Baltimore, Maryland, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
- New York Oncology Hematology
New York, New York, United States
- Willamette Valley Cancer Institute and Research Center
Springfield, Oregon, United States
- Institute of Translational Oncology Research
Greenville, South Carolina, United States
- Texas Oncology - Tyler
Tyler, Texas, United States
- Virginia Oncology Associates
Norfolk, Virginia, United States
- Evergreen Hematology & Oncology
Spokane, Washington, United States
- Vancouver Cancer Center
Vancouver, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2011
- Primary completion
- 31 Dec 2011
- Completion
- 31 Dec 2011
- Last update posted
- 31 Jan 2018
- Registered enrollment
- 30
- Registry id
- NCT00455052
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.